The Power and Promise of Patient-Derived Xenografts of Human Breast Cancer
Article in Cold Spring Harbor Perspectives in Medicine (December 2023)
The most recent citing publications are shown below. View all 19 publications that cite this research output on Dimensions.
Sulindac sulfide as a non-immune suppressive γ-secretase modulator to target triple-negative breast cancer
Article in Frontiers in Immunology (October 2023)
Targeting Mcl-1 by a small molecule NSC260594 for triple-negative breast cancer therapy
Article in Scientific Reports (July 2023)